Menu

Nature Debuts Peer-Review Option

Authors submitting to Nature journals can soon request double-blind reviews.

Feb 18, 2015
Tracy Vence

FLICKR, PETE O'SHEABeginning next month, authors submitting their work to Nature and its associated journals can request double-blind peer review, in which the authors’ names and affiliations will be withheld from reviewers (much like reviewers’ names and affiliations are currently withheld from the authors).

“Advocates of double-blind peer review suggest that it eliminates personal biases, such as those based on gender, seniority, reputation and affiliation,” Nature noted in its February 18 announcement.

In contrast, some researchers have advocated for open peer review, in which the authors and reviewers both are clearly identified, arguing that such increased transparency might further limit bias. But some open-peer-review advocates, such as PhD student Matthew Evans of the John Innes Centre in Norwich, U.K., suggest that, if reviews are to be blinded, double-blind is preferable to single-blind peer review.

“Good scientists will continue to publish good papers in good journals under a double-blind peer review system,” wrote Boyan Garvalov of Justus Liebig University Giessen, Germany, in a January Advances in Regenerative Biology article (hat tip: Alexis Verger). “But every now and again a lesser known research team could make it on the strength of their work against a more famous one, when they would have failed in the single-blind setting—and this would be reason enough for me to endorse the shift to double-blind review.”

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.